|
1
|
Guilland JC, Favier A, de Courcy G Potier,
Galan P and Hercberg S: Hyperhomocysteinemia: An independent risk
factor or a simple marker of vascular disease? 1. Basic data.
Pathol Biol (Paris). 51:101–110. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Koning AB Lawrence, Werstuck GH, Zhou J
and Austin RC: Hyperhomocysteinemia and its role in the development
of atherosclerosis. Clin Biochem. 36:431–441. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clarke R, Daly L, Robinson K, Naughten E,
Cahalane S, Fowler B and Graham I: Hyperhomocysteinemia: An
independent risk factor for vascular disease. N Engl J Med.
324:1149–1155. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Horvath B, Szapary L, Debreceni L, Feher
G, Kenyeres P, Fulop A, Battyani I and Toth K: Effect of Sclerovit
on endothelial dysfunction, hemorheological parameters, platelet
aggregation, plasma concentration of homocysteine and progression
of atherosclerosis in patients with vascular diseases. Clin
Hemorheol Microcirc. 42:19–28. 2009.PubMed/NCBI
|
|
5
|
Briasoulis A, Tousoulis D, Androulakis ES,
Papageorgiou N, Latsios G and Stefanadis C: Endothelial dysfunction
and atherosclerosis: Focus on novel therapeutic approaches. Recent
Pat Cardiovasc Drug Discov. 7:21–32. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Davignon J and Ganz P: Role of endothelial
dysfunction in atherosclerosis. Circulation. 109(23): Suppl 1.
III27–III32. 2004.PubMed/NCBI
|
|
7
|
Martin BJ and Anderson TJ: Risk prediction
in cardiovascular disease: The prognostic significance of
endothelial dysfunction. Can J Cardiol. 25:(Suppl A). A15–A20.
2009. View Article : Google Scholar
|
|
8
|
Chen F, Eriksson P, Kimura T, Herzfeld I
and Valen G: Apoptosis and angiogenesis are induced in the unstable
coronary atherosclerotic plaque. Coron Artery Dis. 16:191–197.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar D and Jugdutt BI: Apoptosis and
oxidants in the heart. J Lab Clin Med. 142:288–297. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cohen O and Kimchi A: DAP-kinase: From
functional gene cloning to establishment of its role in apoptosis
and cancer. Cell Death Differ. 8:6–15. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martinet W, Schrijvers DM, De Meyer GR,
Thielemans J, Knaapen MW, Herman AG and Kockx MM: Gene expression
profiling of apoptosis-related genes in human atherosclerosis:
Upregulation of death-associated protein kinase. Arterioscler
Thromb Vasc Biol. 22:2023–2029. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schumacher AM, Velentza AV and Watterson
DM: Death-associated protein kinase as a potential therapeutic
target. Expert Opin Ther Targets. 6:497–506. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Inbal B, Bialik S, Sabanay I, Shani G and
Kimchi A: DAP kinase and DRP-1 mediate membrane blebbing and the
formation of autophagic vesicles during programmed cell death. J
Cell Biol. 157:455–468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bialik S and Kimchi A: The
death-associated protein kinases: Structure, function, and beyond.
Annu Rev Biochem. 75:189–210. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Raveh T, Droguett G, Horwitz MS, DePinho
RA and Kimchi A: DAP kinase activates a p19ARF/p53-mediated
apoptotic checkpoint to suppress oncogenic transformation. Nat Cell
Biol. 3:1–7. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Michie AM, McCaig AM, Nakagawa R and
Vukovic M: Death-associated protein kinase (DAPK) and signal
transduction: Regulation in cancer. FEBS J. 277:74–80. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen RH, Wang WJ and Kuo JC: The tumor
suppressor DAP-kinase links cell adhesion and cytoskeleton
reorganization to cell death regulation. J Biomed Sci. 13:193–199.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cohen O, Inbal B, Kissil JL, Raveh T,
Berissi H, Spivak-Kroizaman T, Feinstein E and Kimchi A: DAP-kinase
participates in TNF-alpha- and Fas-induced apoptosis and its
function requires the death domain. J Cell Biol. 146:141–148. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pelled D, Raveh T, Riebeling C, Fridkin M,
Berissi H, Futerman AH and Kimchi A: Death-associated protein (DAP)
kinase plays a central role in ceramide-induced apoptosis in
cultured hippocampal neurons. J Biol Chem. 277:1957–1961. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rennier K and Ji JY: Shear stress
regulates expression of death-associated protein kinase in
suppressing TNFα-induced endothelial apoptosis. J Cell Physiol.
227:2398–2411. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rennier K and Ji JY: Effect of shear
stress and substrate on endothelial DAPK expression, caspase
activity, and apoptosis. BMC Res Notes. 6:102013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hua P, Sun M, Zhang G, Zhang Y, Tian X, Li
X, Cui R and Zhang X: Cepharanthine induces apoptosis through
reactive oxygen species and mitochondrial dysfunction in human
non-small-cell lung cancer cells. Biochem Biophys Res Commun.
460:136–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suhara T, Fukuo K, Yasuda O, Tsubakimoto
M, Takemura Y, Kawamoto H, Yokoi T, Mogi M, Kaimoto T and Ogihara
T: Homocysteine enhances endothelial apoptosis via upregulation of
Fas-mediated pathways. Hypertension. 43:1208–1213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang C, Cai Y, Adachi MT, Oshiro S, Aso
T, Kaufman RJ and Kitajima S: Homocysteine induces programmed cell
death in human vascular endothelial cells through activation of the
unfolded protein response. J Biol Chem. 276:35867–35874. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tyagi N, Ovechkin AV, Lominadze D, Moshal
KS and Tyagi SC: Mitochondrial mechanism of microvascular
endothelial cells apoptosis in hyperhomocysteinemia. J Cell
Biochem. 98:1150–1162. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sipkens JA, Hahn N, van den Brand CS,
Meischl C, Cillessen SA, Smith DE, Juffermans LJ, Musters RJ, Roos
D, Jakobs C, et al: Homocysteine-induced apoptosis in endothelial
cells coincides with nuclear NOX2 and peri-nuclear NOX4 activity.
Cell Biochem Biophys. 67:341–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kimchi A: DAP kinase and DAP-3: Novel
positive mediators of apoptosis. Ann Rheum Dis. 58:(Suppl 1).
I14–I19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoo HJ, Byun HJ, Kim BR, Lee KH, Park SY
and Rho SB: DAPk1 inhibits NF-κB activation through TNF-α and
INF-γ-induced apoptosis. Cell Signal. 24:1471–1477. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lemasters JJ: V. Necrapoptosis and the
mitochondrial permeability transition: Shared pathways to necrosis
and apoptosis. Am J Physiol. 276:G1–G6. 1999.PubMed/NCBI
|
|
31
|
Dong D, Wang B, Yin W, Ding X, Yu J and
Kang YJ: Disturbance of copper homeostasis is a mechanism for
homocysteine-induced vascular endothelial cell injury. PloS One.
8:e762092013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
King KL and Cidlowski JA: Cell cycle
regulation and apoptosis. Annu Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
